Pharmacokinetic Interactions Between Hemay005 Tablets and Midazolam Maleate Tablets
Status:
RECRUITING
Trial end date:
2025-05-31
Target enrollment:
Participant gender:
Summary
1. To evaluate the pharmacokinetics of Hemay005 tablets on midazolam and its active metabolite -hydroxymidazolam after multiple administration;
2. Evaluate the effect of Hemay005 tablet on QT interval;
3. To investigate the effect of Hemay 005 tablets on inflammatory factors.